IBM vs STRO · P/E 25, rev $67.53B vs rev $62.0M
International Business Machines (IBM) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported IBM revenue for 2025-12-31 was $67.53B. Net income was $10.59B. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the IBM and STRO stock pages for the full models.
Not investment advice.